Other
Contract with Customer, Liability
Vertex Pharmaceuticals Contract with Customer, Liability increased by 27.3% to $218.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.2%, from $228.40M to $218.70M. Over 5 years (FY 2020 to FY 2025), Contract with Customer, Liability shows a downward trend with a -2.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase indicates higher deferred revenue and future service obligations, while a decrease suggests revenue is being recognized faster than new prepayments are received.
Detailed definition
This represents the obligation to transfer services to a customer for which the entity has received consideration or for...
Peer comparison
Similar to deferred revenue or contract liabilities reported by other asset management and financial services companies.
Metric ID:
other_contract_with_customer_liabilityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $122.60M | $104.10M | $171.70M | $186.10M | $134.80M | $119.50M | $159.60M | $236.40M | $179.10M | $157.10M | $170.30M | $275.80M | $128.30M | $220.00M | $206.80M | $228.40M | $146.90M | $182.00M | $171.80M | $218.70M |
| QoQ Change | — | -15.1% | +64.9% | +8.4% | -27.6% | -11.4% | +33.6% | +48.1% | -24.2% | -12.3% | +8.4% | +61.9% | -53.5% | +71.5% | -6.0% | +10.4% | -35.7% | +23.9% | -5.6% | +27.3% |
| YoY Change | — | — | — | — | +10.0% | +14.8% | -7.0% | +27.0% | +32.9% | +31.5% | +6.7% | +16.7% | -28.4% | +40.0% | +21.4% | -17.2% | +14.5% | -17.3% | -16.9% | -4.2% |
Range$104.10M – $275.80M
CAGR+13.0%
Avg YoY Growth+7.8%
Median YoY Growth+12.2%
Contract with Customer, Liability at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's contract with customer, liability?
- Vertex Pharmaceuticals (VRTX) reported contract with customer, liability of $218.70M in Q1 2026.
- How has Vertex Pharmaceuticals's contract with customer, liability changed year-over-year?
- Vertex Pharmaceuticals's contract with customer, liability decreased by 4.2% year-over-year, from $228.40M to $218.70M.
- What is the long-term trend for Vertex Pharmaceuticals's contract with customer, liability?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's contract with customer, liability has grown at a -2.1% compound annual growth rate (CAGR), from $191.50M to $171.80M.
- What does contract with customer, liability mean?
- The value of services owed to customers for which payment has already been received.